Combining PCNA inhibitors with some conventional anti-cancer therapies, such as chemotherapy, radiotherapy, and immunotherapy, shows synergistic effects and promises improved overall therapeutic outcomes [224, 233, 236]. This evidence concerns the gene PCNA and cancer.